Dry Needling for Treating Spasticity in Multiple Sclerosis
1 other identifier
interventional
10
1 country
1
Brief Summary
The aim of the study is to evaluate the efficacy of dry needling (DN) in the treatment of spasticity in patients with multiple sclerosis (MS). \[Participants and Methods\] participants with MS, with no evidence of a relapse in the last four weeks and with an EDSS (Expanded Disability Sta- tus Scale) greater than 2.5 points (related with pyramidal score) were recruited. DN was performed in lower limbs for 12 consecutive sessions and evaluated with: EDSS (Pyramidal item), Time up and go (TUG), 25 foot, 9hold peg test (9HPT) and the improvement or not in the quality of life (MSQol54) was verified before and after treatment. A follow up visit was carried out to assess improvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable multiple-sclerosis
Started Feb 2018
Typical duration for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 22, 2020
CompletedFirst Submitted
Initial submission to the registry
April 21, 2022
CompletedFirst Posted
Study publicly available on registry
April 28, 2022
CompletedApril 28, 2022
April 1, 2022
2.2 years
April 21, 2022
April 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Change in 9HOLD PEG TEST score
This consists of placing the pegs in the corresponding holes of the 9 holes in the table in the shortest possible time (seconds)
inmediatly before and inmediatly after intervention
Change in 25 foot walk score
patients must walk a distance of 7.25 meters at the fastest and safest speed for them (seconds)
inmediatly before and inmediatly after intervention
Change in Time up and go test score
The participants sit in a chair with their backs supported by the back of the chair and their arms resting on the armrests. The participants are asked to get up from the chair and walk a distance of 3 meters, then the patients turn on themselves (360°), walk back to the chair and sit down again (seconds)
inmediatly before and inmediatly after intervention
Change in Expanded Disability Status Scale (EDSS) score
Each item is valued individually and a score is given, which will then outline the patient's total EDSS ranging from 0 to 10, for use in the exploration sessions. All scans were carried out by a blind explorer.
inmediatly before and inmediatly after intervention
Change in Multiple sclerosis Quality of life-54 (MSQol54) score
questionnaire of 54 items measuring the quality of life of the patient. It can be self-administered or hetero-administered and both physical and mental aspects are measured. Within these there are subscales: among them quality of life in general. Two summary scores, physical health and mental health, can be derived from a weighted combination of scale scores. They range from 0 to 100, where 100 is the highest quality of life (both for physical and mental health)
inmediatly before and inmediatly after intervention
Study Arms (1)
dry needling
EXPERIMENTALThis study has only 1 arm and the control group is their baseline data
Interventions
Only dry needling of the lower limbs will performed in all patients with acupunture needling
Eligibility Criteria
You may qualify if:
- Being a patient diagnosed with multiple sclerosis.
- Being over 18 years of age and less than or equal to 60 years of age.
- Having a score equal to or greater than 2 in the EDSS.
- They need to have a measurement in the following functional systems: P (pyramidal) \>2, CT (brainstem), gait \>2 and sphincter \>2.
- They need to present hypertonia or contractures of the muscles selected for the dry needling, the pain expressed by the patients must be a consequence of spastic processes, have hourly availability to receive therapies and not have needle phobias.
You may not qualify if:
- Having a disease associated with multiple sclerosis that is incompatible with dry needling.
- Being in relapse, or having suffered it in the thirty days prior to starting the treatment. program or taking medications that are contraindicated with the technique applied in the study, (oral anticoagulants.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Santa Cruz De Tenerife, 38320, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
MONSERRAT GONZÁLEZ-PLATAS
Hospital Universitario de Canarias
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physiotherapist
Study Record Dates
First Submitted
April 21, 2022
First Posted
April 28, 2022
Study Start
February 18, 2018
Primary Completion
April 20, 2020
Study Completion
September 22, 2020
Last Updated
April 28, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share